BioCardia, Inc. (BCDA) Net margin 2016–2024
BioCardia, Inc. (BCDA) net profit margin by fiscal year — reported net income divided by reported revenue.
-13700.0%FY2024 · since FY2016: -1789.9% → -13700.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -13700.0% | -11274.2 pp |
| FY2023 | -2425.8% | -1545.1 pp |
| FY2022 | -880.7% | +363.0 pp |
| FY2021 | -1243.6% | +9103.9 pp |
| FY2020 | -10347.6% | -8275.9 pp |
| FY2019 | -2071.7% | +166.2 pp |
| FY2018 | -2237.9% | +331.6 pp |
| FY2017 | -2569.5% | -779.6 pp |
| FY2016 | -1789.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCDA financial trends
BCDA RevenueBCDA Net incomeBCDA Gross profitBCDA Gross marginBCDA Operating incomeBCDA Operating marginBCDA Operating cash flowBCDA Free cash flowBCDA Capital expendituresBCDA Return on equityBCDA Stock buybacksBCDA Dividends paidBCDA Total assetsBCDA Total liabilitiesBCDA Shareholders’ equityBCDA overview →